Clinical Trials Directory

Trials / Terminated

TerminatedNCT02325063

Evaluation of Three Types of Injection for the Treatment of Lateral Epicondylalgia

Leukocyte and Platelet Rich Plasma Versus Type A Botulinum Toxin Versus Glucocorticoids for the Treatment of Lateral Epicondylalgia: a Randomized, Multicenter, Double-blind, Therapeutic Trial With Three Parallel Arms

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
13 (actual)
Sponsor
Centre Hospitalier Universitaire de Nīmes · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The primary objective of this study is to compare the evolution of pain profiles among patients suffering from lateral epicondyalgia (tennis elbow) following three types of treatment: PRP-L injection versus type A botulinum toxin injection versus corticoid injection.

Detailed description

The secondary objectives are to compare the following among the three groups: A- The global efficacy of each treatment defined by a minimum reduction of 25% in average pain over the last 24 hours between 0 and 6 months. B- The evolution of average pain over the last 24 hours between 0 and each different time frame (3 weeks, 6 weeks, 3 months and 6 months). C- The evolution of maximum pain scores using nocturnal post-effort (Jamar grip test) visual analog scales (VAS) between day 0, 3 weeks, 6 weeks, 3 months and 6 months. D- The perception of change on the Patient's Global Impression of Change score (PGIC) at 3 and 6 months E- The evolution of PRTEE scores at 0, 3 and 6 months F- Adverse events at 3 weeks, 6 weeks, 3 months and 6 months. G - Quality of life and utility via the SF-12 at 3 and 6 months. H- The consumption of analgesics.

Conditions

Interventions

TypeNameDescription
DRUGPRP-L InjectionPatients will be treated with an injection of leukocyte and platelet rich plasma.
DRUGBotox injectionPatients will be treated with an injection of Type A Botulinum toxin.
DRUGCorticoid injectionPatients will be treated with an injection of Corticoids.

Timeline

Start date
2015-12-17
Primary completion
2017-05-02
Completion
2017-05-02
First posted
2014-12-24
Last updated
2025-12-10

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02325063. Inclusion in this directory is not an endorsement.